Home > Topic > Coronavirus Vaccine Tracker

CORONAVIRUS VACCINE TRACKER

'I expect that by January, some of the other vaccines could be approved like AstraZeneca’s or one of our own Indian vaccines like the one by Bharat Biotech,' says Kiran Mazumdar-Shaw, MD, Biocon. (Mint)

India to have covid vaccine by June: Kiran Mazumdar-Shaw

2 min read . 24 Oct 2020

Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill. (REUTERS)

Johnson & Johnson, AstraZeneca trials to resume, rejoining vaccine race

3 min read . 24 Oct 2020

FILE PHOTO: A healthcare worker of the free influenza vaccination programme holds a flu vaccine inside a tram, as the global spread of the the coronavirus disease (COVID-19) continues, in Vienna, Austria, October 1, 2020. REUTERS/Lisi Niesner/File Photo (REUTERS)

Germany prepares for coronavirus vaccination before year-end: Report

1 min read . 23 Oct 2020

While the motive behind invasion on Dr Reddy’s isn’t known, it is not a solitary event for a vaccine developer. (Mint)

Dr Reddy’s isolates data servers post cyberattack

2 min read . 23 Oct 2020

The Serum Institute of India has advanced the furthest in clinical trials in India, currently conducting phase 3 trials of Covidshield (AP Photo/Matias Delacroix) (AP)

Govt expects first covid-19 vaccine to be available by Dec

2 min read . 22 Oct 2020

A participant who died during an AstraZeneca Plc Covid-19 trial in Brazil hadn’t received the company’s vaccine. (REUTERS)

Deceased AstraZeneca trial volunteer didn’t receive Covid-19 vaccine: Report

1 min read . 22 Oct 2020

Russia had approved the covid vaccine in August before the final trials

First results from Russian covid vaccine's final trial likely next month

1 min read . 20 Oct 2020

A Moderna Inc. sign is displayed on a shelf during clinical trials for a Covid-19 vaccine at Research Centers of America

Covid vaccine: Moderna targets emergency approval in December

1 min read . 20 Oct 2020

FILE PHOTO: A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine. (REUTERS)

China's experimental coronavirus vaccine CoronaVac is safe: Brazil institute

2 min read . 20 Oct 2020

Anika Chebrolu named America's Top Young Scientist at this year’s 3M Young Scientist Challenge. (Photo: 3M)

Coronavirus cure: Indian-American wins $25,000 for potential covid treatment

3 min read . 19 Oct 2020

Vaccines led by AstraZeneca Plc and the University of Oxford, Pfizer Inc. and BioNTech SE and Moderna Inc. are among those in the final stage of tests,

Getting vaccine doubters to roll up their sleeves won’t be easy

7 min read . 19 Oct 2020

The number of Covid-19 fatalities in India is 114,031, while 6.6 million have recovered from the disease. (AP)

India will tap skill in conducting elections to deliver coronavirus vaccine

1 min read . 18 Oct 2020

With AstraZeneca in a pit stop, vaccines from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership have taken the lead in the race to be first out with a shot. (REUTERS)

Ailments in covid-19 trials raise questions about vaccine method

5 min read . 18 Oct 2020

In this Sept. 24, 2020, file photo, an employee manually inspects syringes of the SARS CoV-2 Vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. (AP Photo/Ng Han Guan, File) (AP)

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

1 min read . 17 Oct 2020

The WHO trial was an open-label trial, in which 11,266 adults from 30 countries were randomized, with 2,750 allocated remdesivir, 954 hydroxychloroquine, 1,411 lopinavir, 651 interferon and lopinavir, 1,412 only interferon, and 4,088 no study drug.

Remdesivir useless in covid fight: WHO

1 min read . 17 Oct 2020

The clinical trials of EpiVacCorona vaccine have been very successful, Russia’s chief sanitary doctor Anna Popova said (REUTERS)

COVID-19 vaccine: WHO in talks with Russia on its second vaccine EpiVacCorona

1 min read . 16 Oct 2020

Pfizer said its vaccine wouldn't be ready until mid-November (AFP)

COVID-19 vaccine race: 42 candidates; spotlight on Moderna, Pfizer, AstraZeneca

3 min read . 16 Oct 2020

The UK government had proposed in August to allow more healthcare workers to administer covid vaccines

UK health service in talks on rollout of potential covid vaccine from December

1 min read . 16 Oct 2020

The antiviral medication, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump's coronavirus infection. Ulrich Perrey/Pool via REUTERS/Files (REUTERS)

Remdesivir did not cut hospital stay or mortality in COVID-19 patients: WHO

1 min read . 16 Oct 2020

A volunteer is injected with an experimental Chinese coronavirus ( COVID-19) vaccine as Turkey began final Phase III trials at Kocaeli University Research Hospital in Kocaeli, Turkey September, 25, 2020. REUTERS/Murad Sezer (REUTERS)

Russia likely to register second coronavirus vaccine this week: Report

1 min read . 14 Oct 2020

x

×

My Reads Redeem a Gift Card Logout